Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
MicroRNA dysregulation in multiple sclerosis.
Molecular pathogenesis of neuromyelitis optica.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.
So many progenitors, so little myelin.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
The Choroid Plexus in Healthy and Diseased Brain.

Pages